These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30287098)

  • 1. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review.
    Hakeem AR; Papoulas M; Menon KV
    Eur J Surg Oncol; 2019 Feb; 45(2):83-91. PubMed ID: 30287098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol.
    Engineer R; Patkar S; Lewis SC; Sharma AD; Shetty N; Ostwal V; Ramaswamy A; Chopra S; Agrawal A; Patil P; Mehta S; Goel M
    BMJ Open; 2019 Jun; 9(6):e028147. PubMed ID: 31253621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer.
    Sirohi B; Mitra A; Jagannath P; Singh A; Ramadvar M; Kulkarni S; Goel M; Shrikhande SV
    Future Oncol; 2015; 11(10):1501-9. PubMed ID: 25963427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications.
    Chaudhari VA; Ostwal V; Patkar S; Sahu A; Toshniwal A; Ramaswamy A; Shetty NS; Shrikhande SV; Goel M
    HPB (Oxford); 2018 Sep; 20(9):841-847. PubMed ID: 29706425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Neoadjuvant Chemotherapy in Localized or Locoregionally Advanced Gallbladder Cancer: A Population-Based and Propensity Score Matched SEER Analysis.
    Xiong YC; Yang ZY; Gong A; Wu ZY; Liu SL; Zhu YD; Song XL; Chu BF; Wu XS; Gong W
    Cancer Control; 2024; 31():10732748241271682. PubMed ID: 39105433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological Downstaging with Neoadjuvant Therapy in Unresectable Gall Bladder Cancer Cases.
    Agrawal S; Mohan L; Mourya C; Neyaz Z; Saxena R
    Asian Pac J Cancer Prev; 2016; 17(4):2137-40. PubMed ID: 27221908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.
    Glazer ES; Liu P; Abdalla EK; Vauthey JN; Curley SA
    J Gastrointest Surg; 2012 Sep; 16(9):1666-71. PubMed ID: 22777053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemoradiotherapy plus postoperative adjuvant XELOX chemotherapy versus postoperative adjuvant chemotherapy with XELOX regimen for local advanced gastric cancer-A randomized, controlled study.
    Wang F; Qu A; Sun Y; Zhang J; Wei B; Cui Y; Liu X; Tian W; Li Y
    Br J Radiol; 2021 Aug; 94(1124):20201088. PubMed ID: 34260297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery.
    Nagakawa Y; Sahara Y; Hosokawa Y; Murakami Y; Yamaue H; Satoi S; Unno M; Isaji S; Endo I; Sho M; Fujii T; Takishita C; Hijikata Y; Suzuki S; Kawachi S; Katsumata K; Ohta T; Nagakawa T; Tsuchida A
    Ann Surg Oncol; 2019 Jun; 26(6):1629-1636. PubMed ID: 30610555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
    JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
    Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
    Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study.
    Wang X; Zhao DB; Yang L; Chi Y; Zhao H; Jiang LM; Jiang J; Tang Y; Li N; Liu WY; Dou LZ; Zou SM; Xue LY; Ren JS; Tian YT; Che X; Guo CG; Bai XF; Sun YM; Wang SL; Song YW; Liu YP; Fang H; Li YX; Jin J
    Front Oncol; 2022; 12():870741. PubMed ID: 35574368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the effectiveness of adjuvant therapy for patients with gallbladder cancer.
    Manterola C; Duque G; Grande L; de Aretxabala X; Conejeros R; Otzen T; García N
    HPB (Oxford); 2019 Nov; 21(11):1427-1435. PubMed ID: 30922845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Chemotherapy for Advanced Gallbladder Cancer: Do We have Enough Evidence? A Systematic Review.
    Naveed S; Qari H; Thau CM; Burasakarn P; Mir AW
    Euroasian J Hepatogastroenterol; 2021; 11(2):87-94. PubMed ID: 34786362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Gallbladder Cancers: A New Paradigm.
    Engineer R; Goel M; Chopra S; Patil P; Purandare N; Rangarajan V; Ph R; Bal M; Shrikhande S; Shrivastava SK; Mehta S
    Ann Surg Oncol; 2016 Sep; 23(9):3009-15. PubMed ID: 27075323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine Carcinoma of Gallbladder: A Step Beyond Palliative Therapy, Experience of 25 Cases.
    Kanetkar AV; Patkar S; Khobragade KH; Ostwal V; Ramaswamy A; Goel M
    J Gastrointest Cancer; 2019 Jun; 50(2):298-303. PubMed ID: 29435905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.